Hers vs Refills: Wegovy® brand vs compounded GLP-1 pricing

Hers vs Refills is primarily a choice between FDA-approved brand-name Wegovy® with ongoing clinician check-ins and a compounded, flat-price GLP-1 plan. Early verdict: choose Hers if you want a brand-name FDA-approved Wegovy® and personalized dose check-ins; choose Refills if you prioritize lower flat pricing and no membership fees.

Direct price and product differences

Price and medication type are the clearest distinctions in this Hers vs Refills comparison. Hers advertises Wegovy® pill from $149/mo and injectable options from $199/mo, and specifies FDA-approved brand-name Wegovy® and no compounded medications. Refills advertises GLP-1 from $99/mo (~$5/day) with flat pricing at every dosage and offers compounded GLP-1 products. Refills also lists tirzepatide at $159/mo where applicable.

See Refills pricing

How each provider describes medication sourcing and regulation

Hers emphasizes FDA-approved brand-name options, stating Wegovy® is FDA-approved and not a compounded product. The source also notes Ozempic® is FDA approved for type 2 diabetes and may be prescribed off-label for weight loss at a clinician’s discretion, and that compounded medications, when offered elsewhere, are not FDA-approved. Refills explicitly offers compounded GLP-1 and repeats that compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. Both providers include regulatory qualifiers about compounded medications.

Ongoing care, support, and membership structure

Hers lists a personalized care team with ongoing dose check-ins and states an active Hers Weight Loss Membership is required, with $39 for the first month and auto-renews at $149/month thereafter; medication is not available without an active membership. Refills highlights 24/7 health concierge support, unlimited clinician consultations at no extra cost, month-to-month plans with no membership or app fees, and free discreet shipping. These statements are captured from each provider’s source materials.

Availability, shipping, and logistics

Refills states free discreet shipping and availability in all 50 US states, with a monthly 4-week supply shipped after prescription processing and tracking updates in about 2 business days. Hers notes that not all options are available in all 50 states and that prescriptions are required; the source captured that treatment and availability depend on clinician determination and state rules.

Comparison table: Hers vs Refills at a glance

Safety and regulatory notes to weigh

Hers emphasizes FDA-approved brand-name Wegovy®, while Refills reiterates that compounded medications are not evaluated by the FDA for safety, effectiveness, or quality. Both providers show that a licensed clinician review and prescription are required, and the sources captured state that treatment is available only when a clinician deems it medically appropriate.

Practical differences in user experience

Refills presents a faster, flat-price workflow with a 3-minute intake quiz and prescription processing that can include a clinician chat or direct prescription within 24 hours, then monthly refill forms. Hers focuses on an ongoing membership with clinician dose check-ins and brand-name prescribing where appropriate. The sources provide these operational descriptions but do not supply direct head-to-head outcome data.

Start Refills signup

Final take on Hers vs Refills

In this Hers vs Refills comparison, choose Hers if you want an FDA-approved brand-name Wegovy® option with a personalized care team and ongoing dose check-ins and accept a required membership. Choose Refills if you prefer lower flat pricing from $99/mo, no membership fees, free discreet shipping, and are considering compounded GLP-1 products with the regulatory qualifiers noted.

Choose Hers if…

you want FDA-approved, brand-name Wegovy® and a structured membership with personalized dose check-ins.

Choose Refills if…

you prioritize flat, lower pricing from $99/mo, free discreet shipping, and no membership or app fees, and understand the compounding regulatory notes.